Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222281
Title: Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review
Author: Harper, Diane M.
Navarro Alonso, José A.
Bosch, F. Xavier
Paavonen, Jorma
Stanley, Margaret
Sasieni, Peter
Yébenes, María
Martínez Martínez, Néstor
Rodriguez, Ángela
García, Andrea
Martín Gomez, Laura
Vallejo Aparicio, Laura
Carrión, Helena
Ruiz García, Yara
Keywords: Vacuna del papil·lomavirus
Càncer de coll uterí
Papillomavirus vaccines
Cervix cancer
Issue Date: 9-Jun-2025
Publisher: Informa UK Limited
Abstract: Cervical cancer is a preventable disease for which vaccines are available to provide long-term protection against human papillomavirus (HPV) infection. This systematic literature review (SLR) was performed to summarize the efficacy, effectiveness, impact, duration of protection, and safety profile of four licensed HPV vaccines against infection, precursor lesions, and cervical cancer. Data was extracted from published reports. The search resulted in 1,136 studies, of which 54 were selected for this review. A substantial decrease in the prevalence of oncogenic HPV types, high-grade cervical lesions, and cervical cancer was found in countries with high vaccine coverage and routine vaccination programs. Post-licensure studies of HPV vaccines have reported high efficacy, effectiveness, and health impact across settings and age groups. Studies emphasize vaccination in younger age groups. These findings may inform future discussions about HPV vaccination strategies.
Note: Reproducció del document publicat a: https://doi.org/10.1080/21645515.2025.2497608
It is part of: Human Vaccines & Immunotherapeutics, 2025, vol. 21, num. 1, p. 2497608
URI: https://hdl.handle.net/2445/222281
Related resource: https://doi.org/10.1080/21645515.2025.2497608
ISSN: 2164-554X
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))



This item is licensed under a Creative Commons License Creative Commons